Delhi High Court Delays Drug Price Control Ruling
This article was originally published in PharmAsia News
Executive Summary
India's Delhi High Court has issued an initial rejection of a petition by one of the country's major pharmaceutical industry organizations for a stay of a regulatory move to subject more than 100 drug products to price control, saying that it wants to hear from the regulator.